An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression

PHASE3CompletedINTERVENTIONAL

Enrollment

288

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

August 31, 2007

Conditions

Depressive Disorder

Interventions

DRUG

SR58611A

Trial Locations (5)

Sanofi-Aventis Administrative Office, Sofia

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Belgrade

Sanofi-Aventis Administrative Office, Bratislava